Therefore, to better capture proteomic changes linked to TDP-43 dysfunction, we applied a molecular subtyping approach, classifying cases into low, intermediate, and high CE burden subtypes, independent of pathological and clinical diagnosis of ADNC and LATE-NC. This evidence concerns the gene TARDBP and cholesteryl ester measurement.